Navigation Links
Spartan Bioscience Announces 6,000-Patient Study of Personalized Medicine for Cardiac Stents
Date:12/20/2012

Ottawa, Ontario (PRWEB) December 20, 2012

Spartan Bioscience today announced the start of a 5,945-patient study of personalized medicine for cardiac stent patients. The study is sponsored by the Center for Individualized Medicine at Mayo Clinic and is entitled “Tailored Antiplatelet Initiation to Lessen Outcomes due to Clopidogrel Resistance after Percutaneous Coronary Intervention (TAILOR-PCI).”

This clinical trial will evaluate whether genotyping of cardiac stent patients at the time of angioplasty can help improve patient outcomes by informing providers about drug selection of either Brilinta® (ticagrelor) or Plavix® (clopidogrel). These antiplatelet drugs are prescribed after surgery to reduce clotting complications, such as heart attacks, strokes, and cardiovascular deaths. The drugs are thought to work differently in patients with specific variations in the CYP2C19 gene, and the Spartan RX CYP2C19 rapid DNA testing system will be used to identify these variations in some patients of the TAILOR-PCI study. The study will enroll patients over a 22-month period at 9 hospitals in Canada and the United States.

The principal investigator of the TAILOR-PCI study is Naveen Pereira, M.D., a Mayo Clinic cardiologist. Chiranjit Rihal, M.D., chairman of the Division of Cardiovascular Diseases at Mayo Clinic in Rochester, Minnesota, serves as chairman of the TAILOR-PCI steering committee. The Mayo Clinic sites are Rochester; Jacksonville, Florida; Phoenix, Arizona; and the Mayo Clinic Health Systems in La Crosse, Wisconsin; and Mankato, Minnesota. Canadian sites participating in this study are St. Michael’s Hospital, Toronto General Hospital, Sunnybrook Hospital, and the University of Ottawa Heart Institute.

“We are excited to work with Mayo Clinic on this landmark clinical trial,” said Paul Lem
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
2. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
3. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
4. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
5. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
6. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
7. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
8. Ohios Bioscience Industry Effort Paying Off With Increase in Graduates and Accolades for the State
9. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
10. Roka Bioscience Secures $47.5 Million in Series D Financing
11. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  Now available is a stem ... Rehealth Regenerative Therapies , located in Guadalajara, ... active people a new health option: stem cell ... age, countless patients suffer from joint and muscle injuries ... muscle tears, torn rotator cuff, tennis elbow, and knee ...
(Date:7/24/2014)... computers have yet to materialise. Yet, scientists are ... such computers faster. One such approach relies on ... by applying an electric field. A new study ... coupled quantum dots (TQDs) with electrical impulses can ... example, should TQDs be used as quantum information ...
(Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
(Date:7/24/2014)... LANSING, Mich. , July 24, 2014  Neogen ... today that future forecasts of its potential revenue from ... conference call to investors and analysts on July 22, ... questioned by analysts regarding this research. "It ... answer questions about the potential of a new type ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Getting More Life out of Lithium-ion Batteries 2Neogen comments on SenesTech 2
... Bacterin International Holdings, Inc. (NYSE Amex: BONE ... material and anti-infective coatings for medical applications, achieved its most ... greater capacity and efficiency in the company,s operational platform, which ... reorganization completed during the month. "As our ...
... Scientists can make graphene out of just about anything with carbon ... Rice University lab of chemist James Tour proved it when they ... show them how it,s done. The work is part of ... scientists described how graphene -- a single-atom-thick sheet of the same ...
... 2011 Interleukin Genetics, Inc. (OTCQB: ILIU) announced ... on Friday, August 12 at 9:30 a.m. EDT to discuss ... live call, dial 877-324-1976 (domestic) or 631-291-4550 (international). The live ... on the Investors section of Interleukin Genetics, Inc.,s Website at ...
Cached Biology Technology:Bacterin Reports New Hires and Management Reorganization, Driving Most Active Processing Month in July 2Bacterin Reports New Hires and Management Reorganization, Driving Most Active Processing Month in July 3Bacterin Reports New Hires and Management Reorganization, Driving Most Active Processing Month in July 4Bacterin Reports New Hires and Management Reorganization, Driving Most Active Processing Month in July 5Bacterin Reports New Hires and Management Reorganization, Driving Most Active Processing Month in July 6One box of Girl Scout Cookies worth $15 billion 2Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2011 Results 2
(Date:7/25/2014)... (NRG1) is a pleiotropic factor characterized by the ... of exons that confer to the protein deeply ... both the myelination occurring during development and the ... nerve: axon degeneration, axon regrowth, remyelination and target ... have discovered that the soluble NRG1 upregulation observed ...
(Date:7/25/2014)... study shows that the age girls reach puberty is influenced ... on which parent contributes the gene. This is the ... development after birth and details of this study were published ... the first period, known as menarche, is a marker for ... that the onset of menses varies between girls, is an ...
(Date:7/25/2014)... the first time, Spanish researchers have detected an unknown ... cells are introduced into a droplet of salt ... sodium chloride crystallisation to create biomineralogical biosaline 3D morphologically ... the material, bacteria are revived. The discovery was made ... the cover of the Astrobiology journal and ...
Breaking Biology News(10 mins):Could age of first period influence development of diseases in older women? 2Bacteria manipulate salt to build shelters to hibernate 2
... DANVILLE, Pa. and PITTSBURGH , July 8 ... status of medication delivery through the use of Aethon,s MedEx system, ... , , , ... the functionality of Aethon,s TUG robots, automatic robotic delivery devices that ...
... by 2050 to address rising population and demand, new ... will suffer unless new approaches to adapt crop plants ... for the remarkable increases in yield accomplished during the ... of the world,s most important crops. "Global ...
... New Orleans, LA Patricia Molina, MD, PhD, Professor ... Orleans, has been awarded a $4 million grant over five ... National Institutes of Health to study how cannabinoids, the principal ... that affect how a person responds to HIV infection. ...
Cached Biology News:Geisinger Implements MedEx System to Enhance Medication Delivery, Tracking 2Geisinger Implements MedEx System to Enhance Medication Delivery, Tracking 3'Business as usual' crop development won't satisfy future demand 2'Business as usual' crop development won't satisfy future demand 3
... compatible with ABI thermal cyclers, QPCR instruments ... characteristics can be sealed with heat ... Certified free of DNase, RNase and human ... Fisher Scientific, the world leader in serving ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~32 kDa DNase IIα chain and the ~40 kDa proenzyme. DNase II causes both DNA condensation and DNA fragmentation. ...
BD BioCoat Vented Caps for 175 cm2 Flasks...
...
Biology Products: